Humana Inc. $HUM Shares Bought by Spire Wealth Management

Spire Wealth Management grew its stake in shares of Humana Inc. (NYSE:HUM) by 10,124.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,828 shares of the insurance provider’s stock after buying an additional 5,771 shares during the period. Spire Wealth Management’s holdings in Humana were worth $1,516,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HUM. Blue Trust Inc. boosted its holdings in Humana by 3.6% in the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after acquiring an additional 48 shares during the last quarter. Private Wealth Management Group LLC increased its stake in Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the last quarter. Atlas Brown Inc. raised its holdings in shares of Humana by 0.9% in the 2nd quarter. Atlas Brown Inc. now owns 6,369 shares of the insurance provider’s stock worth $1,557,000 after purchasing an additional 54 shares during the period. Ossiam raised its holdings in shares of Humana by 1.6% in the 2nd quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock worth $1,070,000 after purchasing an additional 71 shares during the period. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in shares of Humana by 15.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 518 shares of the insurance provider’s stock valued at $135,000 after purchasing an additional 71 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 0.3%

NYSE HUM opened at $276.79 on Friday. The stock has a market cap of $33.29 billion, a P/E ratio of 25.94, a PEG ratio of 2.29 and a beta of 0.45. The company’s fifty day simple moving average is $254.30 and its 200-day simple moving average is $262.31. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. During the same period last year, the firm earned $4.16 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Analyst Ratings Changes

HUM has been the subject of a number of research analyst reports. Wolfe Research dropped their target price on shares of Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a research report on Thursday, November 20th. Wells Fargo & Company downgraded shares of Humana from an “overweight” rating to a “cautious” rating in a research note on Wednesday. Robert W. Baird dropped their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Barclays restated an “underperformer” rating on shares of Humana in a report on Monday. Finally, Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $292.05.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.